MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Bristol-Myers Squibb Co Company Profile (NYSE:BMY)

Consensus Ratings for Bristol-Myers Squibb Co (NYSE:BMY) (?)
Ratings Breakdown: 2 Sell Rating(s), 7 Hold Rating(s), 9 Buy Rating(s)
Consensus Rating:Hold (Score: 2.39)
Consensus Price Target: $73.38 (0.53% upside)

Analysts' Ratings History for Bristol-Myers Squibb Co (NYSE:BMY)
Show:
DateFirmActionRatingPrice TargetActions
6/15/2016Deutsche BankReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/14/2016Jefferies GroupBoost Price TargetHold$76.00 -> $78.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2016Hilliard LyonsInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2016JPMorgan Chase & Co.Reiterated RatingOverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2016ArgusReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/9/2016Credit SuisseBoost Price TargetOutperform$75.00 -> $79.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/29/2016BarclaysBoost Price TargetEqual Weight$70.00 -> $75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/22/2016Berenberg BankReiterated RatingBuy$80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/6/2016Societe GeneraleInitiated CoverageSell$48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/28/2016William BlairReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2016Sanford C. BernsteinBoost Price TargetMarket Perform$67.00 -> $69.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/25/2016BMO Capital MarketsDowngradeOutperform -> Market Perform$74.00 -> $70.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/18/2015Atlantic SecuritiesInitiated CoverageUnderweight$57.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/14/2015Cowen and CompanyReiterated RatingOutperform$75.00 -> $100.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/2/2015GuggenheimUpgradeNeutral -> Buy$82.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/22/2015Morgan StanleyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/24/2015Piper JaffrayUpgradeUnderweight -> Neutral$61.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/14/2015Goldman SachsReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/28/2014FBR & Co.Reiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/27/2014MKM PartnersBoost Price TargetSell$34.00 -> $36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/30/2014 forward)
Earnings History for Bristol-Myers Squibb Co (NYSE:BMY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/21/2016        
4/28/2016Q116$0.65$0.74$4.19 billion$4.39 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/28/2016Q415$0.28$0.38$4.07 billion$4.29 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2015Q315$0.35$0.39$3.83 billion$4.07 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/23/2015Q215$0.36$0.53$3.68 billion$4.16 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2015Q115$0.50$0.71$3.80 billion$4.04 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/27/2015Q414$0.41$0.46$4.02 billion$4.26 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/24/2014Q314$0.42$0.45$3.80 billion$3.92 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/24/2014Q214$0.44$0.48$3.85 billion$3.89 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2014Q114$0.43$0.46$3.89 billion$3.81 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/24/2014Q413$0.43$0.53$4.30 billion$4.44 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/23/2013Q313$0.44$0.46$4.02 billion$4.07 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/25/2013Q2 2013$0.45$0.44$4.07 billion$4.05 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/25/2013Q1 2013$0.41$0.41$3.88 billion$3.83 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/24/2013Q4 2012$0.42$0.47$4.14 billion$4.19 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/24/2012$0.42$0.41ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/25/2012$0.48$0.48ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/26/2012$0.64$0.64ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/26/2012$0.55$0.53ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2011$0.58$0.61ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/28/2011$0.55$0.56ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2011$0.53$0.58ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/27/2011$0.48$0.47ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Bristol-Myers Squibb Co (NYSE:BMY)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.63$0.66$0.64
Q2 20163$0.57$0.65$0.62
Q3 20163$0.60$0.63$0.61
Q4 20163$0.57$0.64$0.60
Q1 20171$0.74$0.74$0.74
Q2 20171$0.80$0.80$0.80
Q3 20171$0.84$0.84$0.84
Q4 20171$0.86$0.86$0.86
(Data provided by Zacks Investment Research)
Current Dividend Information for Bristol-Myers Squibb Co (NYSE:BMY)
Annual Dividend:$1.52
Dividend Yield:2.08%
Payout Ratio:58.46%
Dividend Growth:2.90% (3 Year Average)

Dividend History for Bristol-Myers Squibb Co (NYSE:BMY)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
6/7/2016quarterly$0.382.07%6/29/20167/1/20168/1/2016Tweet This Announcement  Share This Announcement on StockTwits
3/3/2016quarterly$0.382.35%3/30/20164/1/20165/2/2016Tweet This Announcement  Share This Announcement on StockTwits
12/8/2015quarterly$0.382.22%12/30/20151/4/20162/1/2016Tweet This Announcement  Share This Announcement on StockTwits
9/17/2015quarterly$0.372.3%9/30/201510/2/201511/2/2015Tweet This Announcement  Share This Announcement on StockTwits
6/16/2015quarterly$0.372.23%7/1/20157/6/20158/3/2015Tweet This Announcement  Share This Announcement on StockTwits
3/2/2015quarterly$0.372.39%4/1/20154/6/20155/1/2015Tweet This Announcement  Share This Announcement on StockTwits
12/9/2014quarterly$0.372.5%12/30/20141/2/20152/2/2015Tweet This Announcement  Share This Announcement on StockTwits
9/16/2014quarterly$0.362.83%10/1/201410/3/201411/3/2014Tweet This Announcement  Share This Announcement on StockTwits
6/17/2014quarterly$0.363%7/1/20147/3/20148/1/2014Tweet This Announcement  Share This Announcement on StockTwits
3/3/2014quarterly$0.362.55%4/2/20144/4/20145/1/2014Tweet This Announcement  Share This Announcement on StockTwits
12/19/2013quarterly$0.362.7%12/31/20131/3/20142/3/2014Tweet This Announcement  Share This Announcement on StockTwits
9/17/2013quarterly$0.352.95%10/2/201310/4/201311/1/2013Tweet This Announcement  Share This Announcement on StockTwits
6/19/2013quarterly$0.353.14%7/2/20137/5/20138/1/2013Tweet This Announcement  Share This Announcement on StockTwits
3/7/2013quarterly$0.353.74%4/3/20134/5/20135/1/2013Tweet This Announcement  Share This Announcement on StockTwits
12/4/2012quarterly$0.351/4/20132/1/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)
Insider Trading History for Bristol-Myers Squibb Co (NYSE:BMY)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/14/2016John E ElickerSVPSell11,820$72.69$859,195.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2016Charles A BancroftCFOSell30,201$70.79$2,137,928.79View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2016Joseph C CaldarellaSVPSell3,519$72.47$255,021.93View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2016Sandra LeungEVPSell72,544$70.39$5,106,372.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/5/2016Lamberto AndreottiDirectorSell23,200$70.54$1,636,528.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/3/2016Giovanni CaforioCEOSell34,594$71.31$2,466,898.14View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2016Autenried Paul VonSVPSell37,258$71.93$2,679,967.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2016Lamberto AndreottiDirectorSell234,720$71.88$16,871,673.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2016Louis S SchmuklerInsiderSell22,218$71.95$1,598,585.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/5/2016Lamberto AndreottiDirectorSell23,200$65.90$1,528,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/4/2016Lamberto AndreottiDirectorSell11,600$65.79$763,164.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/9/2016Lamberto AndreottiDirectorSell23,200$65.71$1,524,472.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/8/2016Lewis B CampbellDirectorSell2,500$66.00$165,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2016Joseph C CaldarellaSVPSell12,962$64.64$837,863.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/17/2016Giovanni CaforioCEOSell12,040$63.58$765,503.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/17/2016Sandra LeungEVPSell10,152$63.57$645,362.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2016Lamberto AndreottiDirectorSell23,200$59.61$1,382,952.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2016Lamberto AndreottiDirectorSell23,200$67.56$1,567,392.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016Lamberto AndreottiDirectorSell11,600$66.93$776,388.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2015Lamberto AndreottiDirectorSell23,200$69.03$1,601,496.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/20/2015Lamberto AndreottiDirectorSell23,200$67.39$1,563,448.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/6/2015Lamberto AndreottiDirectorSell23,200$60.86$1,411,952.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2015Lamberto AndreottiDirectorSell23,200$59.40$1,378,080.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2015Joseph C CaldarellaSVPSell16,972$65.71$1,115,230.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2015Francis M CussEVPSell114,666$67.81$7,775,501.46View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2015Louis S SchmuklerInsiderSell12,000$66.96$803,520.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/17/2015Sandra LeungGeneral CounselSell11,746$60.39$709,340.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2015Samuel J MoedSVPSell3,880$59.26$229,928.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/6/2015Samuel J MoedSVPSell21,478$60.15$1,291,901.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/29/2015Lamberto AndreottiCEOSell90,246$61.14$5,517,640.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/29/2015Lewis B CampbellDirectorSell2,500$60.89$152,225.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/29/2015Louis S SchmuklerInsiderSell5,250$60.73$318,832.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/5/2014Lamberto AndreottiCEOSell75,000$60.31$4,523,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/24/2014Lamberto AndreottiCEOSell50,000$53.00$2,650,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/6/2014Lamberto AndreottiCEOSell50,000$50.99$2,549,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2014Francis M CussEVPSell63,667$50.77$3,232,373.59View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2014Giovanni CaforioCOOSell26,691$49.87$1,331,080.17View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2014Joseph C CaldarellaSVPSell7,415$51.03$378,387.45View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2014Lamberto AndreottiCEOSell50,000$51.05$2,552,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2014Autenried Paul VonSVPSell20,000$49.89$997,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/29/2014Charles A BancroftCFOSell67,621$51.06$3,452,728.26View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/28/2014Samuel J MoedSVPSell25,752$49.32$1,270,088.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/13/2014Joseph CaldarellaSVPSell9,137$55.20$504,362.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2014Lamberto AndreottiCEOSell100,000$55.52$5,552,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2014Louis SchmuklerInsiderSell8,799$55.81$491,072.19View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/5/2014James CorneliusDirectorSell100,000$55.82$5,582,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/28/2014Louis SchmuklerInsiderSell6,088$54.49$331,735.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2014Giovanni CaforioEVPSell41,563$54.44$2,262,689.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/19/2014John ElickerSVPSell9,534$54.22$516,933.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2014Francis CussEVPSell29,800$54.61$1,627,378.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/14/2014Charles BancroftCFOSell52,963$54.35$2,878,539.05View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/14/2014Sandra LeungGeneral CounselSell10,490$54.28$569,397.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/11/2014Lamberto AndreottiCEOSell86,075$52.66$4,532,709.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/6/2014Joseph CaldarellaSVPSell35,471$48.90$1,734,531.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2014Lewis CampbellDirectorSell2,500$48.28$120,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2014James CorneliusDirectorSell100,000$48.90$4,890,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/29/2013James M CorneliusDirectorSell5,000$43.81$219,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2013Autenried Paul VonSVPSell25,000$47.24$1,181,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/6/2013Joseph C CaldarellaSVPSell26,275$46.53$1,222,575.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2013John E ElickerSVPSell25,997$46.33$1,204,441.01View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2013Lamberto AndreottiCEOSell100,000$47.74$4,774,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2013Samuel J MoedSVPSell58,898$47.38$2,790,587.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2013Elliot SigalEVPSell83,647$48.18$4,030,112.46View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/31/2013Beatrice J CazalaEVPSell91,282$47.00$4,290,254.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/31/2013Giovanni CaforioInsiderSell10,538$47.06$495,918.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/30/2013Beatrice J CazalaEVPSell22,000$47.00$1,034,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2013Charles A BancroftCFOSell25,000$48.68$1,217,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2013James M CorneliusDirectorSell100,000$47.61$4,761,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/23/2013Beatrice J CazalaEVPSell96,000$46.99$4,511,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/23/2013Giovanni CaforioInsiderSell26,647$46.29$1,233,489.63View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/17/2013James M CorneliusDirectorSell225,996$42.99$9,715,568.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/8/2013James M CorneliusDirectorSell20,000$39.85$797,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2013James M CorneliusDirectorSell20,000$39.76$795,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/11/2013James M CorneliusDirectorSell20,000$41.15$823,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/13/2013James M CorneliusDirectorSell20,000$38.18$763,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/13/2013John E ElickerSVPSell3,409$38.51$131,280.59View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/27/2013Giovanni CaforioInsiderSell12,150$37.08$450,522.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/26/2013James M CorneliusDirectorSell20,000$36.58$731,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/17/2013James M CorneliusDirectorSell20,000$34.33$686,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/28/2012James M CorneliusDirectorSell20,000$32.06$641,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/3/2012James M CorneliusDirectorSell20,000$33.71$674,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/10/2012James M CorneliusDirectorSell10,000$31.81$318,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Bristol-Myers Squibb Co (NYSE:BMY)
DateHeadline
06/30/16 10:46 AMBristol-Myers Squibb & PsiOxus Evaluate Potential Drug Combination
06/30/16 10:46 AMBristol-Myers Squibb and PsiOxus Therapeutics announce clinical collaboration to evaluate the combination of Opdivo and Enadenotucirev
06/30/16 10:46 AMPsiOxus, Bristol-Myers Squibb To Evaluate Combination Of Opdivo, Enadenotucirev
06/30/16 10:46 AMBRIEF-Bristol-Myers Squibb, Psioxus Therapeutics announce immuno-oncology clinical collaboration
06/30/16 10:46 AMBristol-Myers Squibb (BMY), PsiOxus Enter Enadenotucirev + Opdivo Combo in Tumors Evaluation Collaboration
06/29/16 07:59 PMBristol-Myers Squibb’s Opdivo receives Breakthrough Therapy Designation from FDA for Bladder Cancer
06/29/16 05:33 PMThese Large Pharmaceutical Stocks Should be on your Radar -
06/29/16 12:10 PMHow Pfizer, Merck May Feel Long-Term Pinch From Brexit -
06/29/16 12:10 PMHow Pfizer, Merck May Feel Long-Term Pinch From Brexit -
06/29/16 09:23 AMBristol-Myers Trades Ex-Dividend Wednesday (BMY) -
06/29/16 08:51 AMMEDIA STATEMENT Bristol-Myers Squibb’s Response to ICER’s Draft Scoping Document “Treatment Options for Advanced Non-Small-Cell Lung Cancer” - [at noodls] - At Bristol-Myers Squibb (BMS), it is our mission to continue to innovate the way cancer is treated by delivering clinically meaningful results―not just incremental improvements―across the entire spectrum ...
06/28/16 08:10 PMShare Update and Earnings Review for Bristol-Myers Squibb Company (NYSE:BMY) - Press Telegraph
06/28/16 08:10 PMGW Pharmaceuticals (NASDAQ:GWPH) & Bristol-Myers Squibb Co (NYSE:BMY) Healthcare Stocks in the News - Wall Street 24
06/28/16 05:00 PMLife or Death: Why Chinese Patients Mix Drug Cocktails at Home -
06/28/16 03:04 PMBristol-Myers Squibb's (BMY) Opdivo Granted FDA Breakthrough Therapy Designation in Adv. Bladder Cancer
06/28/16 03:04 PMBristol-Myers Squibb Co (BMY) Bucks Market Sell-Off on Upbeat Drug News
06/28/16 07:21 AMTop Stock Pick for Quarter: Bristol-Myers Squibb Company (NYSE:BMY) - Engelwood Daily
06/28/16 07:21 AMBristol-Myers Squibb Co (BMY) Bucks Market Sell-Off on Upbeat Drug News - Schaeffers Research (blog)
06/27/16 07:17 PMJim Cramer's 'Mad Money' Recap: 'Brexit' Is the Dumbest Financial Mistake Ever -
06/27/16 02:33 PMEquity Research and Technical Review on Bristol-Myers Squibb Company (NYSE:BMY) - Press Telegraph
06/27/16 02:33 PMBristol-Myers Squibb's (BMY) Opdivo Granted FDA Breakthrough Therapy Designation in Adv. Bladder Cancer - StreetInsider.com
06/27/16 07:33 AMBristol Myers Squibb : BMS in sickle cell partnership to help treat Angolan children
06/27/16 07:33 AMBRIEF-Bristol-Myers Squibb's Opdivo gets breakthrough therapy approval from FDA
06/27/16 06:11 AMBristol-Myers Squibb’s Opdivo (nivolumab) Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Advanced Form of Bladder Cancer - [at noodls] - PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Opdivo for the ...
06/27/16 06:07 AMBristol-Myers Squibb's bladder cancer treatment granted breakthrough therapy designation -
06/25/16 02:51 PMCompany Update: Bristol-Myers Squibb Company (NYSE:BMY) - Sickle Cell Partnership Creates Demonstration ... - Jutia Group (press release) (blog)
06/25/16 02:51 PMBristol-Myers Squibb Company (NYSE:BMY): The Buzzing Stock - Stocks Daily
06/24/16 08:01 PMBristol Myers Squibb : Sickle Cell Partnership Creates Demonstration Project to Treat Children in Angola
06/24/16 08:01 PMCompany Update: Bristol-Myers Squibb Company (NYSE:BMY) – Sickle Cell Partnership Creates Demonstration Project to Treat Children in Angola
06/24/16 03:10 PMSickle Cell Partnership Creates Demonstration Project to Treat Children in Angola - [Business Wire] - The Angola Sickle Cell Initiative, a public-private partnership of the Angola Ministry of Health, the Baylor College of Medicine International Pediatric AIDS Initiative , Texas Children’s Hospital and Chevron, is teaming up with the global biopharmaceutical company Bristol-Myers Squibb to provide children with sickle cell disease in Angola with an effective medication to which many patients in the ...
06/24/16 02:54 PMWhat Were Roche’s Breakthrough Therapy Designations in 2015?
06/24/16 02:54 PMBristol Myers (BMY) Showing Bullish Technicals With Support At $71.81
06/24/16 08:42 AMWhy Investors Are Paying a Premium for These 3 Drugmakers -
06/24/16 06:10 AMSummary of Analysts Rating: Bristol-Myers Squibb Company (NYSE:BMY) , Community Health Systems, Inc. (NYSE ... - Street Updates
06/24/16 06:10 AMIs Bristol-Myers Squibb Co (NYSE:BMY) an Incredibly Valuable Stock? - Street Report
06/23/16 04:27 PMWhy Is Roche Trading at a Discount?
06/23/16 10:58 AMBristol-Myers Squibb a Top Socially Responsible Dividend Stock With 2.1% Yield (BMY)
06/22/16 06:01 PMCramer: Let's Put Brexit in Its Historic Context -
06/22/16 03:04 PMTop Gainers of the Day: Bristol-Myers Squibb Company (NYSE:BMY) from Drug Manufacturers – Major - Twin County News
06/22/16 01:05 PMWhat’s so ‘groundbreaking’ about Curis’ new cancer drug that just began human trials? -
06/22/16 07:40 AMBristol-Myers Squibb Company (NYSE:BMY): Growth Forecast - RealistInvestor.com
06/22/16 07:40 AMStock's Ratings to Focus: Bristol-Myers Squibb Company (NYSE:BMY) , Sarepta Therapeutics, Inc. (NASDAQ:SRPT) - Street Updates
06/22/16 07:36 AMImmuno-Oncology: The Strategic Supernova In Cancer Today -
06/21/16 03:21 PM3 Ways This $30 Billion Market Is Bristol's for the Taking -
06/21/16 10:22 AMBristol-Myers Squibb Co. – Value Analysis (NYSE:BMY) : June 21, 2016 -
06/21/16 07:39 AMCorning Incorporated (NYSE:GLW) & Bristol-Myers Squibb Co (NYSE:BMY) Trend Analysis Report - Wall Street 24
06/20/16 03:20 PMBRISTOL MYERS SQUIBB CO Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib -
06/20/16 03:19 PMMurdo Gordon Appointed Executive Vice President and Chief Commercial Officer - [at noodls] - NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today announced that Murdo Gordon has been appointed executive vice president and chief commercial officer, a newly created position, ...
06/20/16 02:53 PMCan Patients Discontinue Immunotherapy and Still Benefit?
06/20/16 02:05 PMEpizyme Offers Early Data on Non-Hodgkin Lymphoma Drug -
About Bristol-Myers Squibb Co

Bristol-Myers Squibb Co logoBristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company operates in BioPharmaceuticals segment. Its pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes (involving recombinant deoxyribonucleic acid (DNA) technology) called biologics. Its small molecule drugs are administered orally in the form of a pill or tablet. Its biologics are administered to patients through injections or by infusion. It offers products in a range of therapeutic classes, which include virology, including human immunodeficiency virus (HIV) infection; oncology; immunoscience; cardiovascular, and neuroscience. Its products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession. It manufactures products in the United States, Puerto Rico and in over six foreign countries.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: Pharmaceuticals
  • Exchange: NYSE
  • Symbol: BMY
  • CUSIP: 11012210
Key Metrics:
  • Previous Close: $73.00
  • 50 Day Moving Average: $71.82
  • 200 Day Moving Average: $67.11
  • P/E Ratio: 78.69
  • P/E Growth: 1.25
  • Market Cap: $122.29B
  • Current Quarter EPS Consensus Estimate: $2.56 EPS
Additional Links:
Bristol-Myers Squibb Co (NYSE:BMY) Chart for Thursday, June, 30, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha